comparemela.com
Home
Live Updates
Mab Forward Looking Statements - Breaking News
Pages:
Latest Breaking News On - Mab forward looking statements - Page 1 : comparemela.com
I-Mab Announces First Patient Dosed in Phase 3 Registrational Study of CD47 Antibody Lemzoparlimab in MDS in China
GAITHERSBURG, Md. and SHANGHAI, April 24, 2023 /PRNewswire/ I-Mab (the Company ) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company co.
United states
Hong kong
San diego
Gigi feng
Richard yeh
Andrew zhu
Exchange commission
International prognostic scoring system
Company nasdaq
Revised international prognostic scoring system
Mab forward looking statements
Private securities litigation reform act
Operating officer
Chief financial officer
vimarsana © 2020. All Rights Reserved.